Cargando…
Screening for primary aldosteronism is underutilised in patients with chronic kidney disease
BACKGROUND: Primary aldosteronism (PA) is the most common and potentially curable endocrine cause of secondary hypertension, and carries a worse prognosis than essential hypertension. Despite the high prevalence of hypertension in patients with chronic kidney disease (CKD), the screening rates for p...
Autores principales: | Chauhan, Karanjeet, Schachna, Eitan, Libianto, Renata, Ryan, Jessica, Hutton, Holly, Fuller, Peter J., Wilson, Scott, Kerr, Peter G., Yang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300536/ https://www.ncbi.nlm.nih.gov/pubmed/35195879 http://dx.doi.org/10.1007/s40620-022-01267-3 |
Ejemplares similares
-
SAT-558 A Dedicated Endocrine Hypertension Service Increases the Timely Diagnosis of Primary Aldosteronism
por: Yang, Jun, et al.
Publicado: (2020) -
FRI134 Transcriptomic Profiling Of Monocytes To Seek A Potential Biomarker For Primary Aldosteronism
por: Libianto, Renata, et al.
Publicado: (2023) -
A Multicenter Study of Neutrophil-to-Lymphocyte Ratio in Primary Aldosteronism
por: Libianto, Renata, et al.
Publicado: (2020) -
RF32 | PSUN49 To Repeat or Not to Repeat: The Question of Aldosterone and Renin Variability
por: Ng, Elisabeth, et al.
Publicado: (2022) -
Risky business: a single-centre cross-sectional analysis of calculated cardiovascular risk in patients with primary aldosteronism and essential hypertension
por: Solanki, Pravik, et al.
Publicado: (2022)